Purchase Order 75F40126P00185
Award Date 8/31/26
Potential Completion Date 11/2/26
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Food and Drug Administration awarded a purchase order to Mattek Corporation for $81,350 on August 6, 2026, for reconstructed human small intestine and human skin models, microtissue samples, and culture media. The order carries a total small business set-aside. Work is performed in Ashland, Massachusetts, with an ultimate completion date of October 31, 2026.</p>
- <p>The Food and Drug Administration awarded a purchase order to Emulate Inc. for $18,150 on September 2, 2026, covering maintenance, update, and repair of one Emulate Orb and two Emulate Zoe CM-2S units. Emulate qualifies as a small business. Work is performed in Laurel, Maryland. The order carries a firm fixed price and is scheduled for completion by October 2, 2027. No set-aside category applies to this procurement.</p>
- The Food and Drug Administration awarded a purchase order to Global Life Sciences Solutions USA LLC for $39,960.00 on August 14, 2026, covering a preventive maintenance agreement for a Surface Plasmon Resonance Biacore T200 instrument through August 13, 2029. Performance occurs at FDA's Center for Biologics Evaluation and Research Federal Research Center in Silver Spring, Maryland. The agreement provides one scheduled preventive maintenance visit per contract year during business hours using...
- The Food and Drug Administration awarded a $19,266.67 firm fixed-price purchase order to Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip microphysiological systems. The contract, posted in February 2023 with an award date of April 20, 2023, provides a full-service preventative maintenance agreement for two Zoe Culture Modules and two Orb Hub Modules through a base year plus four option years. The contract utilizes no set-aside designation and specifies...
- The Food and Drug Administration has awarded a $158,220 firm fixed-price purchase order to Vitrocell Systems GMBH, a German-based manufacturer of advanced laboratory equipment, for preventative maintenance services on a Vitrocell 24/48 exposure module system located in Jefferson, Arkansas. The contract, awarded on July 22, 2025, with an ultimate completion date of July 27, 2030, supports the FDA's National Center for Toxicological Research and its collaborative work with the Center for Tobacco...
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Vitrocell Systems GMBH, a foreign-owned limited liability company based in Germany. The $611,231.64 firm-fixed-price purchase order is for a "HIGH TEMP SPIKING SYSTEM WITH POST-WARRANTY PREVENTATIVE MAINTENANCE OPTIONS" to support the FDA's research, testing, and evaluation programs. Vitrocell Systems GMBH is a manufacturer of...
- The Food and Drug Administration issued a $23,024.36 delivery order to Government Scientific Source Inc. on July 13, 2026, for parts and accessories for an Eppendorf epMotion 5075 automated liquid handler upgrade under the GSA Multiple Award Schedule. Place of performance is Reston, VA 20191. The order carries a firm fixed price and an ultimate completion date of September 30, 2026. Government Scientific Source Inc. is a small business supplier of laboratory consumables, scientific equipment,...
- The Food and Drug Administration awarded a purchase order to Lonza Walkersville, Inc. for a 4D nucleofection system valued at $24,329.00 on August 17, 2026, with a completion date of December 15, 2026. The system will be installed at FDA/CBER in Silver Spring, Maryland. The equipment is designed to deliver DNA, RNA, and proteins into cell lines (HEK293, CHO, Huh7) and human primary cells using conductive polymer electrodes, process 2104 to 1107 cells per reaction, achieve post-transfection...
- The Food and Drug Administration (FDA) awarded a $16,359 firm fixed-price purchase order to Sartorius Corporation for preventive maintenance and repair services on an IncuCyte S3 Cell Imager at the FDA's facility in Silver Spring, Maryland. The contract, awarded on August 31, 2022, has an ultimate completion date of August 31, 2023, with no set-aside designation. Sartorius Corporation, a subsidiary of German multinational Sartorius Aktiengesellschaft, is a specialized provider of laboratory...
- <p>The Food and Drug Administration issued a purchase order to Stemcell Technologies Inc. valued at $14,171.00 on August 1, 2023 for preventive maintenance and repair service for a Stemcell Technologies StemVision Instrument (serial number SV-00212). Work is performed in Silver Spring, Maryland. The order was firm fixed price with an ultimate completion date of July 31, 2024. No set-aside was applied.</p>